Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre.
The development of Grave's ophthalmopathy (GO) following radioiodine (RI) treatment for Grave's thyrotoxicosis, though controversial, is well described. The development of ophthalmopathy following RI treatment for toxic nodular goitre is much less recognised. We report a 49 year-old female patient who developed thyrotoxicosis and GO after receiving RI treatment for toxic nodular goitre and we also review the relevant literature.
Tahrani
A A
AA
Royal Shrewsbury Hospital, Mytton Oak Road, Shrewsbury, UK. abdtahrani@yahoo.co.uk
Rangan
S
S
Moulik
P
P
D005260:Female; D006044:Goiter, Nodular / Q000532:radiotherapy*; D049970:Graves Ophthalmopathy / Q000209:etiology*; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects* / Q000627:therapeutic use*; D008875:Middle Aged; D011832:Radiation Injuries / Q000175:diagnosis; D013971:Thyrotoxicosis / Q000532:radiotherapy*
D007457:Iodine Radioisotopes